Send Inquiry

Request To Call Back

DECITA DECITABINE INJECTION

Get a Price/Quote

MOQ : 1 Bottle

DECITA DECITABINE INJECTION Specification

Indication
Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia

Dosage Form
Injection

Origin of Medicine
Allopathic

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Decitabine 50 mg

Drug Type
Injection

Ingredients
Decitabine

Physical Form
Liquid

Function
Antineoplastic

Recommended For
Anticancer therapy / Myelodysplastic Syndromes (MDS)

Dosage
As directed by physician

Dosage Guidelines
Intravenous infusion as prescribed

Suitable For
Adults

Quantity
50 mg

Storage Instructions
Store below 30C, protect from light

Therapeutic Class
Anticancer / Cytotoxic agent

Appearance
Clear, colorless to pale yellow solution

Warning
To be administered under medical supervision only

Packaging Type
Glass vial

Route of Administration
Intravenous

Batch No.
Provided on packaging

Shelf Life
24 months

Prescription Required
Yes

Usage
For hospital/institutional use only

Contraindications
Pregnancy, lactation, hypersensitivity to decitabine

MRP
As per local regulations

Marketed By
Samarth Life Sciences Pvt Ltd

DECITA DECITABINE INJECTION Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About DECITA DECITABINE INJECTION

PRODUCT DETAILS

BRAND NAME: DECITA

CONTAINS: DECITABINE

STRENGTH: 50MG

PACKAGING SIZE: PACK OF 1 VIAL

MANUFACTURING BY: NATCO

Note :- DECITAIs APrescription Drug And Should Be Used Under Proper Medical Guidance And Advice.Do Not Share The Medicine With Others, Since They May Be Suffering FromAProblem That Is Not Effectively Treated By This Drug...................

Targeted Anticancer Therapy

DECITA Decitabine Injection delivers effective antineoplastic action against Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. Its mechanism inhibits abnormal cell growth and helps restore normal blood cell production, supporting better health outcomes in eligible adults. Treatment is strictly as per a physicians direction, ensuring optimal benefit and safety.

Safe Handling and Administration

This injection is intended strictly for intravenous use in hospitals or medical institutions, supervised by healthcare professionals. Each vial is single-use, minimizing contamination risks. Proper storagebelow 30C and away from lightpreserves its efficacy for up to 24 months.

FAQs of DECITA DECITABINE INJECTION:

Q: How should DECITA Decitabine Injection be administered?

A: DECITA Decitabine Injection must be administered intravenously under the close supervision of qualified medical personnel in a hospital or institutional setting, as prescribed by your physician.

Q: What conditions does this medicine treat?

A: DECITA is recommended for adults in the management of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia, functioning as an antineoplastic agent to control abnormal cell proliferation.

Q: When is it contraindicated to use DECITA Decitabine Injection?

A: The injection is contraindicated in individuals who are pregnant, breastfeeding, or have hypersensitivity to Decitabine. Always inform your doctor about any relevant conditions before starting treatment.

Q: Where should the injection be stored and for how long?

A: The vial should be stored below 30C in a place protected from light. DECITA has a shelf life of 24 months from the date of manufacture, as indicated on the packaging.

Q: What are the main benefits of DECITA Decitabine Injection?

A: DECITA provides targeted and effective anticancer action in adults with MDS and related leukemia, helping to manage abnormal blood cell growth when treatment is administered as prescribed.